ImmunityBio (IBRX) Profit After Tax (2014 - 2026)
ImmunityBio (IBRX) reported Profit After Tax of -$632.8 million for Q1 2026, down 388.08% year-over-year from $219.7 million in Q1 2025, and down 921.31% quarter-over-quarter from -$62.0 million in Q4 2025.
ImmunityBio (IBRX) Profit After Tax (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has 13 years of Profit After Tax data on file, last reported at -$632.8 million in Q1 2026.
- Profit After Tax for Q1 2026 came in at -$632.8 million, down 388.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$854.6 million (down 108.91% YoY), and the FY2025 annual result was -$351.5 million, up 15.01% from the prior year.
- Profit After Tax fell to -$632.8 million in Q1 2026 per IBRX's latest filing, from -$62.0 million in the prior quarter.
- Over five years, Profit After Tax peaked at -$59.1 million in Q4 2024 and troughed at -$632.8 million in Q1 2026.
- A 5-year average of -$141.1 million and a median of -$107.6 million in 2022 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2026: Profit After Tax jumped 74.68% in 2024, then sank 388.08% in 2026.
- A 5-year view of Profit After Tax shows it stood at -$107.6 million in 2022, then sank by 116.96% to -$233.4 million in 2023, then jumped by 74.68% to -$59.1 million in 2024, then declined by 4.84% to -$62.0 million in 2025, then plunged by 921.31% to -$632.8 million in 2026.
- Business Quant data shows IBRX's Profit After Tax at -$632.8 million in Q1 2026, -$62.0 million in Q4 2025, and -$67.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | ImmunityBio | 7.55 Bn | 7.17 Bn | 43.97 Mn | -632.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -632.78 Mn |
| Dec 31, 2025 | -61.96 Mn |
| Sep 30, 2025 | -67.25 Mn |
| Jun 30, 2025 | -92.57 Mn |
| Mar 31, 2025 | -129.65 Mn |
| Dec 31, 2024 | -59.10 Mn |
| Sep 30, 2024 | -85.73 Mn |
| Jun 30, 2024 | -134.58 Mn |
| Mar 31, 2024 | -134.13 Mn |
| Dec 31, 2023 | -233.39 Mn |
| Sep 30, 2023 | -95.58 Mn |
| Jun 30, 2023 | -138.21 Mn |
| Mar 31, 2023 | -116.58 Mn |
| Dec 31, 2022 | -107.57 Mn |
| Sep 30, 2022 | -111.16 Mn |
| Jun 30, 2022 | -94.84 Mn |
| Mar 31, 2022 | -103.00 Mn |
| Dec 31, 2021 | -91.55 Mn |
| Sep 30, 2021 | -87.63 Mn |
| Jun 30, 2021 | -89.39 Mn |